0001179110-21-007340.txt : 20210702
0001179110-21-007340.hdr.sgml : 20210702
20210702170302
ACCESSION NUMBER: 0001179110-21-007340
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210702
FILED AS OF DATE: 20210702
DATE AS OF CHANGE: 20210702
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Nielsen Kirk G.
CENTRAL INDEX KEY: 0001523522
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40545
FILM NUMBER: 211071217
BUSINESS ADDRESS:
BUSINESS PHONE: 650-233-7877
MAIL ADDRESS:
STREET 1: ONE SANSOME STREET
STREET 2: SUITE 3630
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94104
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CVRx, Inc.
CENTRAL INDEX KEY: 0001235912
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
BUSINESS ADDRESS:
STREET 1: 9201 WEST BROADWAY AVENUE
STREET 2: SUITE 650
CITY: MINNEAPOLIS
STATE: MN
ZIP: 55445
BUSINESS PHONE: 7634162850
MAIL ADDRESS:
STREET 1: 9201 WEST BROADWAY AVENUE
STREET 2: SUITE 650
CITY: MINNEAPOLIS
STATE: MN
ZIP: 55445
FORMER COMPANY:
FORMER CONFORMED NAME: CVRX INC
DATE OF NAME CHANGE: 20030527
4
1
edgar.xml
FORM 4 -
X0306
4
2021-07-02
0
0001235912
CVRx, Inc.
CVRX
0001523522
Nielsen Kirk G.
9201 W BROADWAY AVE #650
#650
MINNEAPOLIS
MN
55445
1
0
0
0
Common Stock
2021-07-02
4
C
0
1461831
A
1461831
I
See Footnote
Series G Preferred Stock
2021-07-02
4
C
0
23125000
0
D
Common Stock
1461831
0
I
See Footnote
Upon the closing of the Issuer's initial public offering, each share of Series G Convertible Preferred Stock automatically converted into shares of common stock at a rate of 1-for-0.0632143218.
These shares are held directly by Vensana Capital I, L.P. ("Vensana I"). The Reporting Person is a Managing Director of Vensana Capital I GP, LLC, the General Partner of Vensana I, and shares voting and dispositive power over the shares held by Vensana I. The Reporting Person disclaims beneficial ownership of all applicable shares except to the extent of his actual pecuniary interest in such shares.
Upon the closing of the Issuer's initial public offering, each share of preferred stock automatically converted into shares of common stock at the then-appliable conversion rate for no additional consideration (subject to the payment of cash in lieu of any fractional shares). The conversion rates reported reflect the conversion ratios under the Issuer's certificate of incorporation, adjusted to give effect to the previously effected 1-for-39.548 reverse stock split of the common stock.
/s/ Amy C. Seidel, Attorney-in-Fact
2021-07-02